Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Giomer vs Sodium Fluoride Varnish for Tooth Hypersensitivity
NCT03818945Phase 4Unknown
- Sponsor
- Cairo University
- Start
- Mar 2019
- Primary completion
- Jun 2019
- Modality
- Implantable Devices
- Countries
- 1
01
Overview
Phase 4, randomised trial of giomer varnish in dentin hypersensitivity (DHS), sponsored by Cairo University. Primary endpoint: Relieving of hypersensitivity at 1 month. Status: unknown.
02
Drugs
giomer varnish
03
Conditions
dentin hypersensitivity (DHS)
Beyond the preview
Go deeper on NCT03818945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03818945.